WO2008145830A3 - Nouveaux composes pro-fluorescents - Google Patents

Nouveaux composes pro-fluorescents Download PDF

Info

Publication number
WO2008145830A3
WO2008145830A3 PCT/FR2007/052631 FR2007052631W WO2008145830A3 WO 2008145830 A3 WO2008145830 A3 WO 2008145830A3 FR 2007052631 W FR2007052631 W FR 2007052631W WO 2008145830 A3 WO2008145830 A3 WO 2008145830A3
Authority
WO
WIPO (PCT)
Prior art keywords
radical
emission
activated
release
pattern
Prior art date
Application number
PCT/FR2007/052631
Other languages
English (en)
Other versions
WO2008145830A2 (fr
Inventor
Pierre-Yves Renard
Anthony Romieu
Jean-Alexandre Richard
Marc Massonneau
Original Assignee
Quidd
Univ Rouen
Pierre-Yves Renard
Anthony Romieu
Jean-Alexandre Richard
Marc Massonneau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quidd, Univ Rouen, Pierre-Yves Renard, Anthony Romieu, Jean-Alexandre Richard, Marc Massonneau filed Critical Quidd
Publication of WO2008145830A2 publication Critical patent/WO2008145830A2/fr
Publication of WO2008145830A3 publication Critical patent/WO2008145830A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/556—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells enzyme catalyzed therapeutic agent [ECTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0026—Acridine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un composé pro-fluorescent de formule générale (I): A-B-X-F(I) dans laquelle A figure une structure labile activable par un phénomène physique, chimique ou biologique,B figure un bras réactif, activable par libération de A et apte à générer un radical portant un substituant nucléophile, éventuellement anionique, ledit radical étant apte à subir un réarrangement intramoléculaire conduisant à la libération de F,X figure un atome de soufre, d' oxygène, un motif OC(O), OC(O)O, OS(O) ou OP(O), F figure un radical fluorophore compatible avec l'établissement d'une liaison éther, thioéther, ester, carbonate, sulfate, sulfinate, sulfonate, phosphate, phosphonate, phosphinate ou aminophosphonate avec B via le motif X et étant tel que le spectre d'émission et/ou d'excitation de F lié à B est décalé relativement au spectre d'émission et/ou d'excitation de F libre.
PCT/FR2007/052631 2006-12-29 2007-12-28 Nouveaux composes pro-fluorescents WO2008145830A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0656061 2006-12-29
FR0656061A FR2910897B1 (fr) 2006-12-29 2006-12-29 Nouveaux composes pro-fluorescents.

Publications (2)

Publication Number Publication Date
WO2008145830A2 WO2008145830A2 (fr) 2008-12-04
WO2008145830A3 true WO2008145830A3 (fr) 2009-03-19

Family

ID=38542979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/052631 WO2008145830A2 (fr) 2006-12-29 2007-12-28 Nouveaux composes pro-fluorescents

Country Status (2)

Country Link
FR (1) FR2910897B1 (fr)
WO (1) WO2008145830A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9400273B1 (en) 2009-12-09 2016-07-26 Life Technologies Corporation 7-hydroxycoumarin-based cell-tracking reagents
EP2760844B1 (fr) 2011-09-29 2018-11-21 Ecole Normale Superieure De Lyon Substrat de peptidase fluorogene
FR2994180B1 (fr) 2012-08-02 2014-08-22 Ecole Norm Superieure Lyon Substrat de glycosidase fluorogene et procede de detection associe
CN108623624A (zh) * 2018-06-12 2018-10-09 兰州大学 一种用探针s-f裸眼鉴别含氟牙膏的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324529A (en) * 1997-02-21 1998-10-28 Merck & Co Inc A combinatorial library based on a tetrapeptide substituted with aminomethylcoumarin for characterizing proteases
WO2006129036A2 (fr) * 2005-05-27 2006-12-07 Quidd Biomarqueur a emission luminescente

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324529A (en) * 1997-02-21 1998-10-28 Merck & Co Inc A combinatorial library based on a tetrapeptide substituted with aminomethylcoumarin for characterizing proteases
WO2006129036A2 (fr) * 2005-05-27 2006-12-07 Quidd Biomarqueur a emission luminescente

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CARL P L ET AL: "A NOVEL CONNECTOR LINKAGE APPLICABLE IN PRODRUG DESIGN", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 24, no. 5, May 1981 (1981-05-01), pages 479 - 480, XP009079818, ISSN: 0022-2623 *
GROOT DE FRANCISCUS M H ET AL: "Elongated Multiple Electronic Cascade and Cyclization Spacer Systems in Activatible Anticancer Prodrugs for Enhanced Drug Release", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 66, 2001, pages 8815 - 8830, XP002212035, ISSN: 0022-3263 *
JONES ET AL: "An image contrast agent selectively activated by prostate specific antigen", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, vol. 14, no. 2, 15 January 2006 (2006-01-15), pages 418 - 425, XP005202852, ISSN: 0968-0896 *
LAXMAN B ET AL: "Noninvasive real-time imaging of apoptosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 99, no. 26, 24 December 2002 (2002-12-24), pages 16551 - 16555, XP002333223, ISSN: 0027-8424 *
WANG Z-Q ET AL: "N-DEVD-N'-morpholinecarbonyl-rhodamine 110: novel caspase-3 fluorogenic substrates for cell-based apoptosis assay", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 15, no. 9, 2 May 2005 (2005-05-02), pages 2335 - 2338, XP004851625, ISSN: 0960-894X *

Also Published As

Publication number Publication date
FR2910897B1 (fr) 2011-05-20
WO2008145830A2 (fr) 2008-12-04
FR2910897A1 (fr) 2008-07-04

Similar Documents

Publication Publication Date Title
BR122018003172B8 (pt) composição aquosa polímera de polivinilamida glioxalada termocurável e papel ou papelão
SG143175A1 (en) Functional fluids comprising alkyl toluene sulfonates
WO2008145830A3 (fr) Nouveaux composes pro-fluorescents
DK2044130T3 (da) Anvendelse af vandige kompositpartikel-dispersioner som bindemiddel i coatings til træ
CL2009000296A1 (es) Dispersion acuosa que comprende mezcla de 2 dispersiones acuosas de poliuretano (pu) o pu-urea, la 1a comprende polimero cristalino o semicristalino de tg de -65 a -40 grados celsius y la 2a comprende polimero amorfo tg de -15 a 10 grados celsius; su procedimiento de preparacion: composiciones adhesivas; y material compuesto adhesivo.
EA200970015A1 (ru) Волокнистые материалы и композиции
MX2007012956A (es) Uso de polimeros de polialquilmetacrilato.
CL2008000776A1 (es) Proceso para el control de la deposicion de material pegajoso organico en un medio acuoso, donde se agrega un producto de reaccion de carbonato de calcio natural con dioxido de carbono y uno o mas acidos.
MX2009006481A (es) Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
HK1133257A1 (fr)
MY144572A (en) Light-shielding pressure-sensitive adhesive sheet
EP1938844A3 (fr) Ciment calcium-phosphate
ATE443741T1 (de) Wässriges beschichtungsmittel auf basis eines bindemittelgemisches als basislack
WO2007019191A3 (fr) Inhibiteurs de la thiazolopyrimidine kinase
BRPI0920813A2 (pt) Recipiente de armazenamento de residuos
BRPI0704154A (pt) composição adesiva, método para ligar substratos, e, artigo
EA200870174A1 (ru) Отверждающие агенты для эпокси-функциональных соединений
EP2388001A3 (fr) Agent anti-âge comportant un composé hétérocyclique ayant une structure spécifique
NO20080874L (no) Fremgangsmate for a dispergere og/eller male opp og/eller konsentrere kalsiumkarbonat i vandige medier ved bruk av en vandig opplosning inneholdende zirkoniumforbindelser
ATE409199T1 (de) Polymere reaktionsprodukte substituierter aminosiloxane
MY149842A (en) Fluid loss additive for oil-based muds
CO6362033A2 (es) Composicion de impermeabilizante base agua para el recubrimiento de diversos sutratos
WO2006032893A3 (fr) Derives de trityle pour spectrometrie de masse amelioree
NO20091597L (no) Puriner som PKC-theta-inhibitorer
MX2009012612A (es) Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07873995

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07873995

Country of ref document: EP

Kind code of ref document: A2